SALIVA
Dr. Nitika Jain
08/04/2023 Saliva 2
Contents
Saliva - as a diagnostic aid (general and perio) Stress biomarkers
Salivary gland diseases Infections Tumours
08/04/2023 Saliva 3
Diagnostic imaging of salivary gland Sialography Contrast sialography
Conclusion References
08/04/2023 Saliva 4
SALIVA - AS A DIAGNOSTIC AID
08/04/2023 Saliva 5
Human saliva performs a wide variety of biological functions that are critical for the maintenance of the oral health.
Saliva, a multi constituent oral fluid, has high potential for the surveillance of general health and diseases.
08/04/2023 Saliva 6
Why saliva???
Non – invasive Limited training No special equipment Potentially valuable for
children and older patients Cost effective Eliminates the risk of
infection Easy, No pain, No needle
prick, Fast Screening of large
population
No Pain
08/04/2023 Saliva 7
What is a biomarker???
A biomarker is an objective measure that has been evaluated and confirmed either as an indicator of physiologic health, a pathogenic process, or a pharmacologic response to a therapeutic intervention.
08/04/2023 Saliva 8
Biomarkers, whether produced by normal healthy individuals or by individuals affected by specific systemic diseases, are tell - tale molecules that could be used to monitor health status, disease onset, treatment response and outcome.
08/04/2023 Saliva 9
Biomarker
Monitor progression / recurrence
Detect disease
Stage disease
Treatment efficacy
Response to treatment
08/04/2023 Saliva 10
CLASSIFICATION OF SALIVARY BIOMARKERS
08/04/2023 Saliva 11
Locally produced proteins of host and bacterial origin
(enzymes, immunoglobulins and cytokines)
Genetic ⁄ genomic biomarkers such as DNA and mRNA of
host origin
Bacteria and bacterial products, ions, steroid hormones and volatile
compounds
Salivary proteomic, genomic and microbial biomarkers for periodontal diagnosis
08/04/2023 Saliva 12
08/04/2023 Saliva 13
08/04/2023 Saliva 14
Salivary proteomic approach as biomarkers
initiates the release of biological mediators from host cells and when exaggerated in nature, leads to host tissue destruction
mediators include proteinases, cytokines and prostaglandins. And bacteria-derived enzymes, such as collagen-degrading enzymes, elastase- like enzymes, trypsin-like proteases, aminopeptidases and dipeptidylpeptidase
08/04/2023 Saliva 15
Periodontopathic bacteria
08/04/2023 Saliva 16
Specific salivary proteomic biomarkers have been identified for three key features of the pathogenic processes in periodontal disease –
inflammation, collagen degradation and bone turnover
08/04/2023 Saliva 17
Neutrophilic polymorphonuclear leukocytes, monocytes and activated macrophages are recruited to the site
release numerous cytokines, such as prostaglandin E2, tumour necrosis factor (TNF), interleukins IL-1 and IL-6, which direct further inflammatory processes
08/04/2023 Saliva 18
Host-derived MMPs
Both MMP-1 (interstitial collagenase) and MMP-8 (polymorphonuclear leukocyte-derived collagenase) gets activated in periodontitis.
MMP-8, which is primarily derived from polymorphonuclear leukocytes during active stages of periodontitis, is a major tissue destructive enzyme in periodontal disease
08/04/2023 Saliva 19
An elevated level of MMP-8 was detected in the saliva of subjects affected by periodontitis compared with healthy patients, but the levels of salivary MMP 1 were similar in both groups.
Therefore, quantification of the level of MMP-8 is a promising candidate for diagnosing and, more importantly, predicting the progression of this episodic disease.
08/04/2023 Saliva 20
Other MMPs, including MMP-2, MMP-3 and MMP-9, were also reported in the saliva of patients affected by periodontitis
08/04/2023 Saliva 21
Salivary biomarkers have been used to examine the effect of lifestyle factors, including smoking, on periodontal health.
Levels of salivary markers including prostaglandin E2, lactoferrin, albumin, aspartate aminotransferase, lactate dehydrogenase, alkaline phosphatase were significantly lower in current smokers than in non-current smokers.
08/04/2023 Saliva 22
08/04/2023 Saliva 23
Biomarkers of bone resorption or turnover
08/04/2023 Saliva 24
Alkaline phosphatase
Three main sources: the actual salivary secretions the GCF, PMNs and tissue degradation; and disposed bacterial cells from dental biofilms
and mucosal surfaces
08/04/2023 Saliva 25
Alkaline phosphatase
Significant correlation between ALP and pocket depth and between ALP and inflammation.
Higher enzyme activity in individuals with periodontal disease than non diseased individuals.
Periodontal destruction by measurement of probing depth, gingival bleeding, and suppuration were related to higher ALP levels in saliva
08/04/2023 Saliva 26
Cathepsin B
Cysteine proteinases Cathepsin B functions in proteolysis 100% sensitivity and 99.8% specificity for
cathepsin B Cathepsin B may have a potential use in
distinguishing periodontitis from gingivitis and in planning treatment and monitoring treatment outcomes
08/04/2023 Saliva 27
CRP
C-reactive protein is a systemic marker released during acute phase of an inflammatory response and is produced by liver. Circulating CRP reaches saliva via GCF or salivary glands. High levels of CRP are associated with chronic and aggressive periodontal diseases.
08/04/2023 Saliva 28
Osteopontin (OPN)
Noncollagenous calcium binding glycosylated phosphoprotein in bone matrix and is produced by several cells including osteoblasts, osteoclasts and macrophages.
Kido et al (2001) demonstrated that OPN level in saliva was increased with progression of periodontal disease. However, no significant difference was observed when OPN level was compared between diseased and healthy sites.
08/04/2023 Saliva 29
Osteocalcin
Is synthesized mainly by osteoblasts. A number of investigators studied
relationship between saliva osteocalcin levels and periodontal diseases.
08/04/2023 Saliva 30
Genomic approach as diagnostic markers
Reports of genetic polymorphisms associated with periodontal disease are increasing, and strong evidence supports the proposal that genes play a role in the predisposition to and progression of periodontal disease.
08/04/2023 Saliva 31
A number of studies have examined links between polymorphisms within host response factors and aggressive periodontitis.
Examination of genes encoding inflammatory cytokines such as IL-1 and TNF α, the anti-inflammatory cytokine IL-10 and the F c- gamma receptors.
08/04/2023 Saliva 32
Reactive oxygen species, participate in the pathogenesis of periodontal tissue destruction.
DNA damage, lipid peroxidation, protein disruption and stimulation of inflammatory cytokine release.
8-hydroxy-deoxyguanosine, a product of oxidative DNA damage, is a biomarker for detecting periodontitis in human subjects.
08/04/2023 Saliva 33
Advantages to using genomic and transcriptomic markers to detect disease: The marker discovery process is high-
throughput, involving the use of genome-wide microarray platforms
08/04/2023 Saliva 34
Till now,68 up-regulated and six down-regulated genes was identified, including lactotransferrin, MMP-1, MMP-3, interferon induced-15, keratin 2A and desmocollin-1, and this result was confirmed by real-time polymerase chain reaction.
08/04/2023 Saliva 35
Stress biomarkers in saliva
Salivary α-amylase Chromogranin A Salivary cortisol
08/04/2023 Saliva 36
Salivary cortisol
Its level in saliva is lower than that in blood Advantage of salivary over serum cortisol
measurement is the minimisation of stress from fear of needles during collection, which may bias the results.
08/04/2023 Saliva 37
Salivary – α amylaseChromogranin A
biomarkers of acute stress and a-amylase is better
Both salivary CgA and a-amylase are considered biomarkers of the stress response by the sympatho–adreno–medullary system, unlike cortisol, which is considered a biomarker of stress response by the Hypothalamic pituitary adrenal system.
08/04/2023 Saliva 38
08/04/2023 Saliva 39
Various other diagnosis
Candidiasis – Through the presence of candida spp in saliva
The presence of periodontal pathogenic bacteria can also be diagnosed by this method - increasing the risk of cardiovascular and cerebrovascular diseases.
08/04/2023 Saliva 40
Cystic fibrosis Cystic fibrosis (CF) is a genetically
transmitted disease of children and young adults, which is considered a generalized exocrinopathy. CF is the most common lethal autosomal-recessive disorder.
The abnormal secretions present in CF caused clinicians to explore the usefulness of saliva for the diagnosis of the disease.
08/04/2023 Saliva 41
CF patients contains increased calcium levels.
Resulted in a calcium-protein aggregation which caused turbidity of saliva.
Higher occurrence of calculus as compared with healthy controls.
The levels of neutral lipids,phospholipids, and glycolipids are elevated.
08/04/2023 Saliva 42
21-Hydroxylase deficiency an inherited disorder of steroidogenesis which
leads to congenital adrenal hyperplasia. In non-classic 21-hydroxylase deficiency, a partial deficiency of the enzyme is present.(Carlson et al., 1999).
In 21- hydroxylase deficiency, a strong correlation has been found between 17- hydroxyprogesterone levels in saliva and serum.
08/04/2023 Saliva 43
In some malignant diseases, markers can be detected in saliva, such as the presence of protein p53 in patients with oral squamous cell carcinoma.
Other biomarkers for OSCC: M2BP MRP14 CD59 Profilin Catalase
08/04/2023 Saliva 44
The presence of the c- erb- 2 tumour marker in the saliva and blood serum of breast cancer patients and its absence in healthy women is a promising tool for the early detection of this disease.
In ovarian cancer too, the CA 125 marker can be detected in the saliva with greater specificity and less sensitivity than in serum.
08/04/2023 Saliva 45
PCR detection of H. pylori in the saliva show high sensitivity.
The presence of antibodies to other infectious organisms such as Borrelia burdogferi, shigella can also be detected in saliva.
Detection of hepatitis A and hepatitis B surface antigen in the saliva has been used in epidemiological studies.
08/04/2023 Saliva 46
In neonates the presence of Ig A is an excellent marker of rota virus infection
HIV antibody detection is as precise in saliva as in serum and is both applicable in clinical and epidemiological studies.
Salivary and oral fluid test: Orasure ( available in USA)
08/04/2023 Saliva 47
SALIVARY GLAND DISORDERS
08/04/2023 Saliva 48
Salivary gland disorders
Bacterial infections Acute bacterial parotitis Chronic bacterial parotitis Chronic recurrent juvenile parotitis Acute suppurative submandibular sialadenitis Chronic recurrent submandibular sialadenitis Acute allergic sialadenitis
Viral infections Mumps HIV/AIDS Cytomegalovirus
08/04/2023 Saliva 49
Fungal infections Mycobacterial infections
Tuberculosis Atypical mycobacteria
Parasitic infections Autoimmune-related infections
Systemic lupus erythematosus Sarcoidosis Sjogren’s syndrome
08/04/2023 Saliva 50
Sialolithiasis
• Sialolithiasis is the formation or presence of a calculus or calculi in a salivary gland.
• It is most commonly seen in the submandibular gland and duct (about 80% of cases), then the parotid gland and duct .
• Sialolithiasis is rare in the sublingual gland. • Most stones are solitary, but multiple stones may
be present. • The reason why a stone forms is unknown
08/04/2023 Saliva 51
Symptoms:• May be asymptomatic • Dull pain from time to time over the affected
gland • Swelling of the gland• Pain with chewing or swallowing Complications• Oral infection
08/04/2023 Saliva 52
Sialadenitis
• The salivary glands contain a network of ducts. Saliva flows through them into the mouth. If the flow is reduced or stopped for some reason, infection can grow. This infection called sialadenitis .
• The most common infection is bacterial.• Sialadenitis is most common in the parotid
gland and the submandibular gland.
08/04/2023 Saliva 53
Symptoms:• Tender, painful lump in cheek or under chin. • Pus may drain through the gland into the mouth. • If the infection spreads, fever, chills and malaise
may occur.
Complication• Oral infection.• Upper respiratory tract infection.• Upper GIT infection.
08/04/2023 Saliva 54
XEROSTOMIA
08/04/2023 Saliva 55
XEROSTOMIA: Epidemiology
Medication Autoimmune disease (Sjogren’s syndrome, lupus) Systemic diseases (diabetes, asthma, kidney,
sarcoidosis, HIV) Stress/anxiety/depression Radiation therapy to the head and neck
30 Gy = glandular fibrosis (gland can still produce some saliva)
60-70 Gy = glandular destruction (gland can no longer produce saliva)
Factors that Affect Salivary Flow
08/04/2023 Saliva 56
Gender (70 % female, usually postmenopausal)
Sympathomimetic medications (stimulate the sympathetic nervous system)
Parasympatholytic medications (inhibit the parasympathetic nervous system)
Antacid Antianxiety Anticholinergic Anticonvulsant Antidepressant Antiemetic Antihistamine Antihypertensive Antiparkinsonian Antipsychotic
Factors that Affect Salivary FlowXEROSTOMIA: Epidemiology
•Cholesterol reducing•Decongestant•Diet pills•Diuretic•Hormonal replacement therapy•Muscle relaxant•Narcotic analgesic•Sedative•Bronchodilator
Over 400 Medications Can Produce the Side Effect of Xerostomia
57Saliva
XEROSTOMIA: Epidemiology
Factors that Affect Salivary Flow
Age
o Studies show that among non-institutionalized people not taking medication, neither the quantity or quality of saliva change significantly with age
o Studies show a positive correlation between the number of drugs taken and the incidence and severity of xerostomia
58Saliva
Xerostomia is the term used for the symptom of oral dryness. While oral dryness is most commonly associated with a reduction in salivary gland output (termed salivary gland hypofunction), the symptom may be reported by patients with apparently normal salivation who have changes in saliva composition.
XEROSTOMIA: Etiology
“Dry Mouth”
59Saliva
08/04/2023 Saliva 60
Xerostomia affects 25% of the population and is becoming one of the fastest-growing oral health Medications are the cause of more than 90% of xerostomia cases 32 million Americans today take three or more medications daily Xerostomia was not a great problem in the past because people did not take as many medications as they do today
XEROSTOMIA: Etiology
Prevalence
08/04/2023 Saliva 61
The reported prevalence of dry mouth varies widely due to the methodological and population differences in various studies.
Prevalence has been estimated to range from 10% to 38%, with 20% the most commonly reported figure
Xerostomia is becoming increasingly common in developed countries
where adults are living longer and poly-pharmacy is very common.
XEROSTOMIA: Etiology
Global Prevalence
Viscous saliva Sticky saliva Difficulty speaking Difficulty swallowing Halitosis Altered taste Complaint of dryness Complaint of burning mouth, lips, or tongue Altered sense of smell
XEROSTOMIA: Diagnosis
Symptoms
62Saliva
Increased caries Food sticking to the oral structures Frothy saliva Gingivitis Absence of saliva Cracking and fissuring of the tongue Ulceration of oral mucosa No pooling of saliva in the floor of the mouth Recurrent candidal infections A toothbrush, mouth mirror, or instrument that sticks to the soft
tissues Poorly fitting prostheses
XEROSTOMIA: Diagnosis
Signs
63Saliva
08/04/2023 Saliva 64
Perform oral hygiene at least 4 times daily, after each meal and before bedtimes Use fluoride toothpaste Rinse with a salt and baking soda solution 4 to 6 times daily Avoid citrus juices (oranges, grapefruit, tomatoes) Rinse and wipe oral cavity immediately after meals Keep water handy to moisten the mouth at all times Avoid liquids and foods with high sugar content Avoid rinses containing alcohol and salty foods Brush and rinse dentures after meals Apply prescription-strength fluoride get at bedtime as prescribed Use moisturizers regularly on the lips Try salivary substitutes or artificial saliva preparations
XEROSTOMIA: Diagnosis Simple Management Strategies for Patients
08/04/2023 Saliva 65
Saliva substitutes - contents Xanthan gum Sodium carboxymethylcellulose Potassium chloride Sodium chloride Magnesium chloride Calcium chloride Di-potassium hydrogen orthophosphate Potassium di-hydrogen orthophosphate Sodium fluoride Sorbitol Methyl p-hydroxybenzoate Spirit of lemon
08/04/2023 Saliva 66
Commercially available: Orabalance XERO – Lube Salivart Optimoist
08/04/2023 Saliva 67
Some patients are predisposed to candidiasis because of the lack of salivary histatins
Recommendation: o Antifungal medication can be recommended to control fungal growth
XEROSTOMIA: Management
08/04/2023 Saliva 68
XEROSTOMIA: Management
Treatment of Xerostomia-Associated Problems
08/04/2023 Saliva 69
XEROSTOMIA: Management
Treatment of Xerostomia-Associated Problems
GETTING INVOLVED IN DIAGNOSING XEROSTOMIA CAN BE A
WINDOW TO PATIENTS’ OVERALL HEALTH
Diagnosing xerostomia is an important diagnostic tool for other systemic diseases. The signs and symptoms of xerostomia are often associated with
and/or result from other conditions.
XEROSTOMIA
70Saliva
08/04/2023 Saliva 71
Salivary gland Neoplasia
Tumors of the salivary glands are uncommon and represent 2-4% of head and neck neoplasms.
80 % of tumors occur within the parotid glands & most of the others in the submandibular glands.
Males and females are affected equally. 70% to 80% of these tumors are benign.
08/04/2023 Saliva 72
Salivary gland neoplasia
Benign Warthin's tumor (benign papillary cystadenoma) Benign mixed tumors Monomorphic adenoma Benign lymphoepithelial lesions
Malignant Mucoepidermoid carcinoma Adenoid cystic carcinoma Adenocarcinoma Malignant mixed tumor
08/04/2023 Saliva 73
Benign tumors
Benign mixed tumors Is the most common tumor of the major salivary
glands. Pathologically, it is characterized by slow growth and few symptoms.
Warthin's tumor (benign papillary cystadenoma) A slow-growing, cystic tumor that almost always
occurs in older men.
08/04/2023 Saliva 74
Benign tumors
Monomorphic adenoma Are a group of benign lesions with a variety of growth patterns. These
lesions usually are found in the parotid glands.
Benign lymphoepithelial lesions Include a wide range of cystic changes that share the common
denominator in atypical lymphoid hyperplasia. These changes are found often in patients infected with HIV.
08/04/2023 Saliva 75
Malignant tumors
Mucoepidermoid carcinoma • Is unique in that the tumors it produces can vary
in aggressiveness from low-grade and slow growing to high-grade and rapidly growing.
• It occurs more frequently than any other malignancy of the major salivary glands.
08/04/2023 Saliva 76
Malignant tumours
Adenoid cystic carcinoma• Account for 25% of malignant salivary gland
tumors and 15% of all parotid gland tumors. • Occur most often in the minor, rather than major,
salivary glands. • The disease is unique in that its tumors grow
slowly, but metastasize readily.
08/04/2023 Saliva 77
Malignant tumours Adenocarcinoma
• Are most frequently found in the minor salivary glands of the nose and paranasal sinuses.
• Account for 15% of malignancies of the parotid and 10% of malignancies of the submandibular glands.
Malignant mixed tumor• Make up approximately 15% and 12% of parotid
and submandibular neoplasms respectively. • The disease typically is characterized by slow,
protracted growth.
08/04/2023 Saliva 78
Drug monitoring in saliva
molecular size, lipid solubility, and the degree of ionization of the drug
molecule, as well as the effect of salivary pH and the
degree of protein binding of the drug
08/04/2023 Saliva 79
Therapeutic Drugs
Antipyrine Caffeine Carbamazepine Cisplatin Cyclosporine Diazepam Digoxin Ethosuximide
Irinotecan Lithium Methadone Metoprolol Oxprenolol Paracetamol Phenytoin Primidone
08/04/2023 Saliva 80
Saliva and age
With age, a generalized loss of salivary gland parenchymal tissue loss.
Salivary acini are replaced by adipose tissue.
Decreased production of saliva
08/04/2023 Saliva 81
DIAGNOSTIC IMAGING FOR SALIVARY GLAND
08/04/2023 Saliva 82
Diagnostic imaging for salivary gland
To differentiate inflammatory from neoplastic diseases
Differentiate diffuse from focal suppurative disease
Identify and localize sialoliths Demonstrate ductal morphology
08/04/2023 Saliva 83
Methods
Plain film radiography Intra oral radiography Extra oral radiography Conventional sialography Computed tomography ( CT) Magnetic resonance imaging Scintigraphy Ultrasonography
08/04/2023 Saliva 84
Conventional Sialography
A radiographic technique wherein a radiopaque contrast agent is infused into the ductal system of a salivary gland before imaging.
Imaging is done with plain films, fluoroscopy, panoramic radiography, CT.
Mainly submandibular and parotid
08/04/2023 Saliva 85
Technique
A lacrimal or periodontal probe is used to dilate the sphincter at the ductal orifice before the passage of a cannula, blunt needle or catheter, which is connected to a syringe containing contrast agent.
08/04/2023 Saliva 86
Indications
Contraindications
08/04/2023 Saliva 87
Phases of sialography Ductal phase Acinar phase Post – evacuation phase
08/04/2023 Saliva 88
Contrast sialography
Lipid soluble agents 37% iodine e.g.: ethiadol
Water soluble agents 28 to 38 % iodine e.g.: hypaque 50%,
hypaque M 75%, renografin 60, isopaque, triosol, dionosil.
08/04/2023 Saliva 89
Computed tomography
08/04/2023 Saliva 90
Magnetic resonance imaging
08/04/2023 Saliva 91
Sialoendoscopy
Specialized procedure that uses a small video camera at the end of a flexible cannula, which is introduced into the ductal orifice.
Both diagnostically and therapeutic Can demonstrate the strictures and kinks
in the ductal system, as well as mucous plugs.
08/04/2023 Saliva 92
Conclusion
Biomarkers of disease in succession play an important role in life sciences and have begun to assume a greater role in diagnosis, monitoring and therapy outcomes and drug discovery.
The challenge for biomarkers is to allow earlier detection of disease evolution and more robust therapy efficacy measurements.
08/04/2023 Saliva 93
References
Top Related